EUROAPI SAS EO 1
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry;… Read more
Market Cap & Net Worth: EUROAPI SAS EO 1 (940)
EUROAPI SAS EO 1 (F:940) has a market capitalization of $124.32 Million (€121.11 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #19954 globally and #2132 in its home market, demonstrating a -2.60% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying EUROAPI SAS EO 1's stock price €1.27 by its total outstanding shares 95213556 (95.21 Million).
EUROAPI SAS EO 1 Market Cap History: 2022 to 2026
EUROAPI SAS EO 1's market capitalization history from 2022 to 2026. Data shows change from $1.36 Billion to $124.32 Million (-44.86% CAGR).
EUROAPI SAS EO 1 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how EUROAPI SAS EO 1's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 940 by Market Capitalization
Companies near EUROAPI SAS EO 1 in the global market cap rankings as of March 18, 2026.
Key companies related to EUROAPI SAS EO 1 by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
EUROAPI SAS EO 1 Historical Marketcap From 2022 to 2026
Between 2022 and today, EUROAPI SAS EO 1's market cap moved from $1.36 Billion to $ 124.32 Million, with a yearly change of -44.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €124.32 Million | -42.70% |
| 2025 | €216.97 Million | -20.77% |
| 2024 | €273.85 Million | -50.79% |
| 2023 | €556.50 Million | -58.99% |
| 2022 | €1.36 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of EUROAPI SAS EO 1 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $124.32 Million USD |
| MoneyControl | $124.32 Million USD |
| MarketWatch | $124.32 Million USD |
| marketcap.company | $124.32 Million USD |
| Reuters | $124.32 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.